Cargando…

Two male siblings with a novel LRBA mutation presenting with different findings of IPEX syndrome

INTRODUCTION: LPS-responsive beige-like anchor (LRBA) protein deficiency is a disease of immune dysregulation with autoimmunity affecting various systems. CASE PRESENTATION: Two male siblings with a novel LRBA mutation had different primary findings at admission: the younger sibling had chronic earl...

Descripción completa

Detalles Bibliográficos
Autores principales: Eren Akarcan, Sanem, Edeer Karaca, Neslihan, Aksu, Guzide, Aykut, Ayca, Yilmaz Karapinar, Deniz, Cetin, Funda, Aydinok, Yesim, Azarsiz, Elif, Gambineri, Eleonora, Cogulu, Ozgur, Ulusoy Severcan, Ezgi, Alper, Hudaver, Kutukculer, Necil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Microbiology Society 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249428/
https://www.ncbi.nlm.nih.gov/pubmed/30479781
http://dx.doi.org/10.1099/jmmcr.0.005167
Descripción
Sumario:INTRODUCTION: LPS-responsive beige-like anchor (LRBA) protein deficiency is a disease of immune dysregulation with autoimmunity affecting various systems. CASE PRESENTATION: Two male siblings with a novel LRBA mutation had different primary findings at admission: the younger sibling had chronic early-onset diarrhoea and the elder one had autoimmune haemolytic anaemia. During long-term follow-up for IPEX phenotype, both developed hypogammaglobulinaemia, enteropathy and lung involvement. The patients partially responded to immunosuppressive therapies. A homozygous c.2496C>A, p.Cys832Ter (p.C832*) mutation in the LRBA gene causing a premature stop codon was detected. After molecular diagnosis, abatacept, as a target-specific molecule, was used with promising results. CONCLUSION: LRBA deficiency is a recently defined defect, with variable presentations in different patients; a single, definitive treatment option is thus not yet available.